| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |